companydata.dkEir Diagnostics ApS: Financial statements 2020
CVR: 40339396
Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,454,928 and a net result of DKK -368,613. Equity amounted to DKK 5,204,830. The solvency ratio was 81.5%.
- Gross Profit
- 1,454,928 kr.
- Profit/Loss
- -368,613 kr.
- Equity
- 5,204,830 kr.
- Total Assets
- 6,385,481 kr.
How creditworthy is Eir Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Eir Diagnostics ApS has published its interim report for the period March 12, 2019 – December 31, 2019.
On March 18, 2020, the company changed its name from AptaZense ApS to Eir Diagnostics ApS.
About Eir Diagnostics ApS
Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.